Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Deepa Bhojwani; Richard Sposto; Nirali N Shah; Vilmarie Rodriguez; Constance Yuan; Maryalice Stetler-Stevenson; Maureen M O'Brien; Jennifer L McNeer; Amrana Quereshi; Aurelie Cabannes; Paul Schlegel; Claudia Rossig; Luciano Dalla-Pozza; Keith August; Sarah Alexander; Jean-Pierre Bourquin; Michel Zwaan; Elizabeth A Raetz; Mignon L Loh; Susan R Rheingold

doi:10.1038/s41375-019-0426-8

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Leukemia. 2019 Apr;33(4):1061-1062. doi: 10.1038/s41375-019-0426-8.

Authors

Deepa Bhojwani¹, Richard Sposto², Nirali N Shah³, Vilmarie Rodriguez⁴, Constance Yuan³, Maryalice Stetler-Stevenson³, Maureen M O'Brien⁵, Jennifer L McNeer⁶, Amrana Quereshi⁷, Aurelie Cabannes⁸, Paul Schlegel⁹, Claudia Rossig¹⁰, Luciano Dalla-Pozza¹¹, Keith August¹², Sarah Alexander¹³, Jean-Pierre Bourquin¹⁴, Michel Zwaan¹⁵, Elizabeth A Raetz¹⁶, Mignon L Loh¹⁷, Susan R Rheingold¹⁸

Affiliations

¹ Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. dbhojwani@chla.usc.edu.
² Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
³ National Cancer Institute, Bethesda, MD, USA.
⁴ Mayo Clinic, Rochester, MN, USA.
⁵ Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
⁶ University of Chicago Medicine Comer Children's Hospital, Chicago, IL, USA.
⁷ Oxford University Hospitals, Oxford, UK.
⁸ University Hospital Saint-Louis, Paris, France.
⁹ University Children's Hospital of Würzburg, Würzburg, Germany.
¹⁰ University Children's Hospital of Münster, Münster, Germany.
¹¹ Children's Hospital at West-mead, Sydney, Australia.
¹² Children's Mercy Hospital, Kansas City, MO, USA.
¹³ The Hospital for Sick Children, Toronto, Canada.
¹⁴ University Children's Hospital, Zurich, Switzerland.
¹⁵ Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
¹⁶ New York University Langone Medical Center, New York, NY, USA.
¹⁷ Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
¹⁸ Childrens Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA.

Abstract

We thank the research coordinators and following physicians at pediatric cancer centers for contributing data to this project: Prashant Hiwarkar and Jayashree Motwani, Birmingham Women's and Children's Hospital, UK; Kelly Malone, Children's Hospital of Colorado, USA; Mylene Bassal, Children's Hospital of Eastern Ontario, Canada; Yoav Messinger and Joanna Perkins, Children's Hospital of Minnesota, USA; Van Huynh, Children's Hospital of Orange County, USA; Richard Ho, Children's Hospital at Vanderbilt, USA; Joanne Chuah and Jessa Morales, Children's Hospital at Westmead, Australia; Donald Wells, Dell Children's Hospital, USA; Nicolas Boissel, Hospital Saint-Louis, France; Tannie Huang, Kaiser Permanente, USA; Stacey Marjerrison, McMaster Children's Hospital, Canada; William Carroll and Joanna Pierro, New York University Langone Medical Center, USA; Ajay Vora, Sheffield Children's Hospital, UK; Donna Lancaster, The Royal Marsden Hospital, UK; Lucie Šrámková, University Hospital Motol, Czech Republic; Chatchawin Assanasen, University of Texas Health Science Center, San Antonio, USA; Rupert Handgretinger, University of Tübingen, Germany.

Publication types

Published Erratum

Grants and funding

Z99 CA999999/ImNIH/Intramural NIH HHS/United States